These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8111834)

  • 61. [Present status in the development of new antineoplastic agents].
    Klener P
    Cas Lek Cesk; 1994 Jan; 133(1):6-9. PubMed ID: 8111834
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Disorders of the cardiovascular system during treatment of oncologic diseases].
    Elbl L
    Vnitr Lek; 2002 Jul; 48(7):619-25. PubMed ID: 12197403
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Perspectives of medical therapy of solid tumours].
    Koza I
    Vnitr Lek; 2001 Aug; 47(8):510-5. PubMed ID: 15633386
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [New trends in antineoplastic chemotherapy].
    Klener P
    Vnitr Lek; 1994 Jun; 40(6):386-90. PubMed ID: 8073651
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-emetic therapy in cancer chemotherapy: current status.
    Herrstedt J; Dombernowsky P
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [High-dose chemotherapy--a new hope for some patients with malignant tumors?].
    Mayer J
    Vnitr Lek; 1997 Dec; 43(12):809-14. PubMed ID: 9601895
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New agents in medical oncology and the risk of venous thromboembolism.
    Manzoni M; Bencardino K; Piovella F; Chatzileontiadou S; Delfanti S; Riccardi A; Danova M; Corazza GR
    J Exp Clin Cancer Res; 2007 Jun; 26(2):185-94. PubMed ID: 17725097
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pyrimidines as the chemotherapeutic drugs.
    Cieplik J; Królicki ZA
    Acta Pol Pharm; 1992; 49(4):59-66. PubMed ID: 16092437
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Current status of new drugs for the treatment of patients with multiple myeloma.
    Kenealy M; Prince HM
    Intern Med J; 2006 Dec; 36(12):781-9. PubMed ID: 17096741
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Calcium antagonists as amplifiers of the mutagenicity of cytostatic drugs].
    Scheid W; Traut H
    Wien Med Wochenschr; 1993; 143(19-20):522-6. PubMed ID: 8135036
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The interactions of antiepileptic drugs in oncology practice].
    Armijo JA; Sánchez MB; Campos C; Adín J
    Rev Neurol; 2006 Jun 1-15; 42(11):681-90. PubMed ID: 16736404
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Economics of new oncology drug development.
    DiMasi JA; Grabowski HG
    J Clin Oncol; 2007 Jan; 25(2):209-16. PubMed ID: 17210942
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New antiretrovirals and new combinations.
    Havlir DV; Lange JM
    AIDS; 1998; 12 Suppl A():S165-74. PubMed ID: 9632999
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sulindac and its derivatives: a novel class of anticancer agents.
    Haanen C
    Curr Opin Investig Drugs; 2001 May; 2(5):677-83. PubMed ID: 11569947
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical evaluation of new quinolones as antituberculosis drugs].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 1999 Jan; 74(1):71-5. PubMed ID: 10067058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.